Article
Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma
26 Jan 2014
Abstract excerpt
BACKGROUND: Glioblastoma multiforme (GBM) is one of the most aggressive human tumors, and the establishment of an effective therapeutic reagent is a pressing priority. Recently, it has been shown that the tumor tissue consists of heterogeneous components and that a highly aggressive population should be the therapeutic target. METHODS: Through a single subcutaneous passage of GBM cell lines LN443 and U373 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
